Gastric cancer is the second leading cause of cancer death worldwide (Roder, 2002). The prognosis is generally poor, with an overall 5-year survival of approximately 20% in most countries. The median ...
Toxicity was evaluated before each treatment cycle as described in the National Cancer Institute Common Toxicity Criteria (NCI CTC) version 3.0. In cases of grade 3/4 neutropenia of over 5 days ...
Neoadjuvant therapy for adenocarcinomas of the duodenum and ampulla of Vater. Background: This phase II study evaluated efficacy of fixed dose rate (FDR) infusion of gemcitabine (10mg/m 2 /min) and ...
Phase II study of induction chemotherapy (ICT) with gemcitabine (G) and vinorelbine (V) followed by concurrent chemoradiation therapy (CCRT) with oral etoposide (E) and cisplatin (P) for inoperable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results